Steward Partners Investment Advisory, LLC Novartis Ag Transaction History

Steward Partners Investment Advisory, LLC

$9.37 Billion
Q2 2024

A detailed history of Steward Partners Investment Advisory, LLC transactions in Novartis Ag stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 45,675 shares of NVS stock, worth $5.29 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

45,675

Previous 44,594 2.42%

Holding current value

$5.29 Million

Previous $4.31 Million 12.73%

% of portfolio

0.05%

Previous 0.05%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$92.57 - $107.37 $100,068 - $116,066	1,081 Added 2.42%	45,675 $4.86 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $689,754 - $785,322	7,240 Added 19.38%	44,594 $4.31 Million
Q4 2023 Feb 12, 2024	BUY	$92.27 - $101.54 $200,133 - $220,240	2,169 Added 6.16%	37,354 $3.77 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $115,665 - $128,363	1,221 Added 3.59%	35,185 $3.58 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $612,482 - $694,504	6,620 Added 24.21%	33,964 $3.43 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $115,083 - $133,460	1,438 Added 5.55%	27,344 $2.52 Million
Q4 2022 Feb 15, 2023	SELL	$75.55 - $92.52 $20,549 - $25,165	-272 Reduced 1.04%	25,906 $2.35 Million
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $66,850 - $78,184	-896 Reduced 3.31%	26,178 $1.99 Million
Q2 2022 Aug 04, 2022	SELL	$80.52 - $93.75 $6,763 - $7,875	-84 Reduced 0.31%	27,074 $2.29 Million
Q1 2022 May 02, 2022	BUY	$80.11 - $90.62 $377,878 - $427,454	4,717 Added 21.02%	27,158 $2.38 Million
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $106,638 - $117,917	-1,338 Reduced 5.63%	22,441 $1.96 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $1.64 Million - $1.91 Million	-20,106 Reduced 45.82%	23,779 $1.95 Million
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $1.21 Million - $1.34 Million	14,218 Added 47.93%	43,885 $4 Million
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $502,169 - $592,198	6,014 Added 25.43%	29,667 $2.54 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $25,450 - $30,784	-326 Reduced 1.36%	23,653 $2.23 Million
Q3 2020 Oct 30, 2020	BUY	$82.14 - $91.0 $193,275 - $214,123	2,353 Added 10.88%	23,979 $2.09 Million
Q2 2020 Aug 06, 2020	BUY	$80.93 - $91.1 $156,518 - $176,187	1,934 Added 9.82%	21,626 $1.89 Million
Q1 2020 Apr 29, 2020	BUY	$70.67 - $99.01 $26,077 - $36,534	369 Added 1.91%	19,692 $1.62 Million
Q4 2019 Jan 17, 2020	BUY	$84.35 - $95.37 $120,030 - $135,711	1,423 Added 7.95%	19,323 $1.83 Million
Q3 2019 Oct 30, 2019	SELL	$85.54 - $94.26 $121,980 - $134,414	-1,426 Reduced 7.38%	17,900 $1.56 Million
Q2 2019 Jul 25, 2019	SELL	$75.4 - $92.8 $421,787 - $519,123	-5,594 Reduced 22.45%	19,326 $1.76 Million
Q1 2019 Apr 30, 2019	BUY	$75.32 - $86.15 $280,792 - $321,167	3,728 Added 17.59%	24,920 $2.4 Million
Q4 2018 Jan 15, 2019	BUY	$73.66 - $82.02 $65,041 - $72,423	883 Added 4.35%	21,192 $1.82 Million
Q3 2018 Oct 23, 2018	BUY	$66.94 - $77.43 $106,836 - $123,578	1,596 Added 8.53%	20,309 $1.75 Million
Q2 2018 Jul 20, 2018	BUY	$64.91 - $73.36 $181,748 - $205,408	2,800 Added 17.6%	18,713 $1.41 Million
Q1 2018 Apr 20, 2018	BUY	$70.39 - $84.15 $62,647 - $74,893	890 Added 5.92%	15,913 $1.29 Million
Q4 2017 Jan 19, 2018	BUY	$72.33 - $77.64 $37,249 - $39,984	515 Added 3.55%	15,023 $1.26 Million
Q3 2017 Nov 22, 2017	BUY	$74.14 - $77.27 $79,922 - $83,297	1,078 Added 8.03%	14,508 $1.25 Million
Q2 2017 Nov 22, 2017	BUY	N/A	7,890 Added 142.42%	13,430 $1.12 Million
Q1 2017 Nov 22, 2017	BUY	N/A	654 Added 13.39%	5,540 $411,000
Q4 2016 Nov 22, 2017	BUY	N/A	4,886	4,886 $355,000

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Novartis Ag Transaction History